Skip to content

Drug interactions

Dapagliflozin-metformin + Etonogestrel

Severity: Minor

Dapagliflozin-metformin and Etonogestrel: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Progestins such as etonogestrel can slightly impair glucose tolerance and insulin sensitivity in some patients. The effect is usually small with implants and rarely changes diabetes control meaningfully.

What this interaction means in plain words

Dapagliflozin-metformin and Etonogestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dapagliflozin-metformin belongs to Endocrine; Etonogestrel belongs to Endocrine.

Evidence level: Low

Why it happens

Progestogens may modestly reduce insulin sensitivity, giving weak pharmacodynamic antagonism of antihyperglycemic effects.

What to do

No routine change is needed; check glycemic control (glucose, HbA1c) at usual intervals after starting the implant and adjust antidiabetic therapy only if control worsens.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin-metformin and Etonogestrel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin-metformin with Etonogestrel?

MediHelp rates the interaction as minor. Dapagliflozin-metformin and Etonogestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Progestins such as etonogestrel can slightly impair glucose tolerance and insulin sensitivity in some patients. The effect is usually small with implants and rarely changes diabetes control meaningfully.

How serious is the interaction between Dapagliflozin-metformin and Etonogestrel?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; check glycemic control (glucose, HbA1c) at usual intervals after starting the implant and adjust antidiabetic therapy only if control worsens.

What other medicines interact with Dapagliflozin-metformin?

MediHelp also lists interactions of Dapagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Dapagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in